Group sequential designs for cancer immunotherapy trial with delayed treatment effect-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Group sequential designs for cancer immunotherapy trial with delayed treatment effect

Published:2023-02-05 Issue:1 Volume:34 Page:1-15
ISSN:1054-3406
Container-title:Journal of Biopharmaceutical Statistics
language:en
Short-container-title:Journal of Biopharmaceutical Statistics

Author:

Wu Jianrong¹,Li Yimei²,Zhu Liang³

Affiliation:

1. Division of Epidemiology, Biostatistics, and Preventive Medicine, University of New Mexico, Albuquerque, NM, USA

2. Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, TN

3. Internal Medicine, University of Texas Health Science Center, Houston, TX, USA

Funder

National Cancer Institute

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/10543406.2023.2170403

Reference19 articles.

1. Fleming, T. R., and D. P. Harrington. 1991. Counting processes and survival analysis. New York: John Wiley and Sons.

2. Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab

3. Sample size determination for the weighted log-rank test with the Fleming-Harrington class of weights in cancer vaccine studies

4. Group sequential monitoring based on the weighted log-rank test statistic with the Fleming-Harrington class of weights in cancer vaccine studies

5. Jennison, C., and B. W. Turnbull. 2000. Group sequential tests with applications to clinical trials. Boca Raton, FL: Chapman and Hall/CRC.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP